Latest Biotech News

A reflective analysis underscores the paramount role of collaboration in advancing scientific breakthroughs, challenging the myth of solitary genius. Examples include the Polymath Project’s rapid...

The LSX USA Congress, scheduled for mid-September 2025 in Boston, will bring together senior executives, investors, and biotech innovators from across the US. The event promises dynamic networking...

Sarepta Therapeutics has halted shipments of its FDA-approved Duchenne muscular dystrophy gene therapy Elevidys for non-ambulatory patients following the second recent death from acute liver...

Bristol Myers Squibb appointed Chris Shibutani, M.D., formerly a senior biotech analyst at Goldman Sachs, as EVP and chief strategy officer. Shibutani combines clinical experience as an...

A research team led by W. Zeng and colleagues has developed a millimeter-scale magnetic soft robot capable of simultaneous locomotion and environmental sensing. Published in npj Flexible...

Recent studies underscore novel biomarkers and pathological features in Parkinson’s disease and atypical parkinsonism. One cohort study, published in npj Parkinson’s Disease, identified...

Researchers at the University of Illinois Urbana-Champaign engineered a novel solid-state nanopore platform using 2D materials, advancing label-free single-biomolecule detection technology....

A study led by Professor Philip Moons demonstrated the capability of AI, using Google NotebookLM, to produce podcasts summarizing scientific research effectively. The AI-generated content received...

The MOVEO project officially launched in Málaga, Spain, brings together 16 partners from nine countries to develop sustainable, integrated transport solutions across Europe. Funded by Horizon...

The extensive US budget bill under Senate consideration includes significant changes impacting pharma, including reform proposals for the Inflation Reduction Act’s Medicare drug price negotiation...

Genetic testing firm 23andMe agreed to be acquired by a nonprofit led by co-founder Anne Wojcicki for $305 million, prevailing in a final bidding round over Regeneron. This transaction concludes a...

Innovent Biologics advances their PD-1 × IL-2 antibody fusion IBI363 into registrational studies after demonstrating Phase I/II efficacy across three cold tumor types. This bispecific approach...

Sarepta Therapeutics has suspended shipments of its Duchenne muscular dystrophy gene therapy, Elevidys, for non-ambulatory patients following a second fatality caused by acute liver failure. Both...

Anne Wojcicki, co-founder and ex-CEO of 23andMe, has prevailed in a bankruptcy auction for the company's assets by bidding $305 million through her nonprofit TTAM Research Institute. This offer...

The FDA has approved pembrolizumab, an immune checkpoint inhibitor, for patients with resectable locally advanced head and neck squamous cell carcinoma expressing PD-L1 (CPS≥1). Approval was based...

Recent studies have uncovered novel insights into Parkinson’s disease pathology and progression. Researchers identified changes in cutaneous nerve fibers linked to Parkinson’s and atypical...

Engineering innovations include a novel solid-state nanopore sensing platform developed by University of Illinois researchers enabling label-free single-biomolecule detection, enhancing prospects...

The 25-year milestone of the Human Genome Project's first draft is marked by reflections from key figures, including Francis Collins and J. Craig Venter. Their insights highlight the...

The proteomics field is witnessing strategic partnerships aligning gene sequencing with advanced protein analysis technologies. Ultima Genomics collaborates with Olink Proteomics, leveraging...

Bristol Myers Squibb appoints Chris Shibutani, M.D., a former Goldman Sachs biotech analyst and practicing anesthesiologist, as EVP and Chief Strategy Officer to guide long-term strategy and...